現在、価格および在庫状況を閲覧できません。
おすすめの製品
由来生物
mouse
品質水準
100
500
結合体
unconjugated
抗体製品の状態
diluted ascites fluid
抗体製品タイプ
primary antibodies
クローン
1F5, monoclonal
詳細
For In Vitro Diagnostic Use in Select Regions (See Chart)
フォーム
buffered aqueous solution
交差性
human
包装
vial of 0.1 mL concentrate (401M-14)
vial of 0.5 mL concentrate (401M-15)
bottle of 1.0 mL predilute (401M-17)
vial of 1.0 mL concentrate (401M-16)
bottle of 7.0 mL predilute (401M-18)
メーカー／製品名
Cell Marque®
テクニック
immunohistochemistry (formalin-fixed, paraffin-embedded sections): 1:10-1:50
アイソタイプ
IgG2a
コントロール
synovial sarcoma
輸送温度
wet ice
保管温度
2-8°C
視覚化
nuclear
遺伝子情報
human ... TLE1(7088)
詳細
Transducin-like enhancer protein 1 (TLE1) is a protein encoded by the gene TLE1 and is involved in the control of hematopoiesis, neuronal, and terminal epithelial differentiation. Positive immunohistochemical nuclear staining with anti-TLE1 has been shown to be useful for identifying synovial sarcoma. TLE1 expression may also be observed in other soft tissue neoplasms, usually at low levels.
品質
 IVD |  IVD |  IVD |  RUO |
関連事項
TLE1 Positive Control Slides, Product No. 401S, are available for immunohistochemistry (formalin-fixed, paraffin-embedded sections).
物理的形状
Solution in Tris Buffer, pH 7.3-7.7, with 1% BSA and <0.1% Sodium Azide
調製ノート
Download the IFU specific to your product lot and formatNote: This requires a keycode which can be found on your packaging or product label.
その他情報
For Technical Service please contact: 800-665-7284 or email: [email protected]
法的情報
Cell Marque is a registered trademark of Merck KGaA, Darmstadt, Germany
適切な製品が見つかりませんか。
製品選択ツール.をお試しください
最新バージョンのいずれかを選択してください：
試験成績書（COA）
Lot/Batch Number
Kemal Kosemehmetoglu et al.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 22(7), 872-878 (2009-04-14)
TLE1, a transcriptional repressor essential in hematopoiesis, neuronal differentiation and terminal epithelial differentiation, has recently been shown in a single tissue microarray study to be a highly sensitive and relatively specific marker of synovial sarcomas. Expression of TLE1 has not
Marc El Beaino et al.
Sarcoma, 2020, 7192347-7192347 (2020-04-24)
Synovial sarcoma can present morphologically in multiple forms, including biphasic and monophasic subtypes. As a result, the histological diagnosis can sometimes be challenging. Transducin-Like Enhancer 1 (TLE1) is a transcriptional corepressor that normally is involved in embryogenesis and hematopoiesis but
Jefferson Terry et al.
The American journal of surgical pathology, 31(2), 240-246 (2007-01-27)
Synovial sarcoma is a soft tissue malignancy defined by the SYT-SSX fusion oncogene. Demonstration of the t(X;18) by cytogenetics, fluorescence in situ hybridization or reverse-transcriptase polymerase chain reaction has become the gold standard for diagnosis, but practical considerations limit the
Amanda Jagdis et al.
The American journal of surgical pathology, 33(12), 1743-1751 (2009-10-08)
Synovial sarcoma is a high-grade soft tissue sarcoma that can be challenging to diagnose on the basis of histology alone. It is defined by a characteristic translocation t(X;18) that produces the fusion oncogene SYT-SSX. The current diagnostic gold standard for
アクティブなフィルタ
ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.
製品に関するお問い合わせはこちら（テクニカルサービス）
